* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Insulin-like growth factors - California State University, Long Beach
NMDA receptor wikipedia , lookup
G protein–coupled receptor wikipedia , lookup
Tissue engineering wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell membrane wikipedia , lookup
Cell encapsulation wikipedia , lookup
Cell growth wikipedia , lookup
Cellular differentiation wikipedia , lookup
Cell culture wikipedia , lookup
Endomembrane system wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cytokinesis wikipedia , lookup
Paracrine signalling wikipedia , lookup
The Growth Inhibitory Role and Cell Membrane Association of a Reptilian Insulin-Like Growth Factor Binding Protein Larissa Balogh Endocrine Laboratory California State University at Long Beach Research Advisor: Dr. Kevin M. Kelley Insulin-like growth factors • Insulin-like growth factors (IGFs) are growthstimulatory peptides • IGF-I receptor activates cell growth • Insulin receptor transduces metabolic functions INS/IGF Precursor (before vertebrate emergence) INS IGFBP introduced IGF (early vertebrates?) ? IGFBP Cell Membrane INS-Receptor IGF-Receptor (metabolic) (growth) Slide by Dr. Kevin Kelley IGF-binding proteins • IGF-binding proteins (IGFBPs) are the integrators of the endocrine growthregulatory apparatus block IGF interaction with insulin receptors regulate IGF bioactivity IGF-independent effects • Six principal mammalian IGFBPs • Little is known about non-mammalian IGFBPs • IgH-2 cell line derived from heart epithelial cells of the reptile, Iguana iguana IgH-2 Iguana heart cell single IGFBP, binds 125I-IGF-I binds cell membrane surface removal of cell-surface IGFBP Photo by Dr. Underwood, CSULB using a Nikon E800 microscope with a magnifier CCD camera Hypothesis • The membrane-bound Iguana IGFBP serves an IGF-inhibitory role in the heart cells IGF arriving at the cellular site is removed from proximity to the growth receptor cell surface IGFBP IGF-I receptor Goals • Determine the effects of IGF-I on cellsurface associated IGFBP (without potential IGF activation of IGF receptor signaling) • Determine the effects of the IGFBP on the cells mitogenic response to IGF-I • Establish if the Iguana IGFBP cell-surface associates by utilizing a RGD sequence IGF-I analogs [Ala31][Leu60]IGF-I Des(1-3)IGF-I IGF-I Cell surface IGFBP IGF-I receptor Materials and Methods Time and dose dependent removal of IGFBP IgH-2 cells Western Ligand Blot of treatment media IGF-I [Ala31][Leu60]IGF-I Des(1-3)IGF-I Affinity cross-linking of cell monolayer Materials and Methods Effects of the IGFBP on the cells Thymidine Incorporation assay mitogenic response to IGF-I • Two subsets of cells “ IGFBP present” and “IGFBP removed” • Treatment with IGF-I or Des(1-3)IGF-I • Addition of [3H]thymidine • Counted on LSC Materials and Methods Competitive inhibition IgH-2 cellsof IGFBP cell membrane binding Western Ligand Blot of treatment media GRGDSP synthetic peptide GRGESP synthetic peptide Affinity cross-linking of cell monolayer Results • Time and dose dependent removal of the IGFBP from the cell surface 15 minute incubation with [Ala31][Leu60]IGF-I IGF receptor (135 kDa) 0 1nM 3nM 0.1M 1M IGF Des IGFBP bound with 125I-IGF-I (37 kDa) Released IGFBP (30 kDa) Rat Serum Results • Effect of the IGFBP on the cells mitogenic response to IGF-I Thymidine incorporation IGF-I IGF-I ([Ala][ Leu]IGF-I pretreated) Des(1-3)IGF-I 2.2 c fold stimulation 2 1.8 1.6 b 1.4 a a 1.2 a a 1 0.8 0 1 50 IGF-1 (ng / ml) 100 Results • Competitive inhibition of IGFBP cell surface association by a RGD synthetic peptide GRGDSP (M) IGF receptor (135 kDa) RGE 0 25 50 100 500 IGF IGFBP bound with 125I-IGF-I (37 kDa) Released IGFBP (30 kDa) Rat Serum Conclusions • IgH-2 IGFBP removal from the cell surface by IGF-I is time and dose dependent, but independent of IGF-I activation of receptor signaling functions to inhibit IGF-I growth stimulation cell surfaces associates through a RGD amino acid sequence • Future research will be directed towards the cloning of this IGFBP Acknowledgments I would like to thank: - Dr. Kevin Kelley, Kathleen Sak, Kameron Schmidt, and all the other members of the CSULB Endocrine Lab - Howard Hughes Medical Institute